PAION AG Release: Recruitment of Phase II/III Study With Short-Acting Anaesthetic/Sedative Remimazolam (Ono's Development Code: ONO-2745) in Japan is Completed
5/8/2013 9:57:37 AM
More...
|
PAION Announces Patient Recruitment for Phase IIa Study with its Short Acting Anesthetic/Sedative CNS 7056 Successfully Completed
9/8/2009 10:21:25 AM
More...
|
PAION to Present at Five Upcoming Conferences
9/8/2009 9:20:57 AM
More...
|
PAION Reports Results for the First Half Year 2009
8/5/2009 9:52:15 AM
More...
|
Financial News: PAION: Announcement according to Articles 37v-x et seqq. of the WpHG [German Securities Trading Act] with the objective of Europe-wide Distribution
7/29/2009 9:06:20 AM
More...
|
PAION: Phase Ib and IIa Studies of the Anesthetic/Sedative CNS 7056 on Track
7/15/2009 9:19:49 AM
More...
|
PAION Reports Results for the First Quarter 2009
5/13/2009 10:02:49 AM
More...
|
PAION Completes First Part of Phase Ib Study of the Anesthetic/Sedative CNS 7056
5/11/2009 10:39:54 AM
More...
|
PAION Initiates Phase Ib Study of the Anesthetic/Sedative CNS 7056 in Volunteers Undergoing Colonoscopy
4/20/2009 10:00:29 AM
More...
|
PAION Initiates Phase II Trial with its Anesthetic/Sedative CNS 7056
4/15/2009 10:01:31 AM
More...
|
|